Author:
Sampath Kuber T.,Grgurevic Lovorka,Vukicevic Slobodan
Publisher
Springer International Publishing
Reference83 articles.
1. Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, Tomasoni S, Zanchi C, Longaretti L, Donadelli R, Remuzzi G (2002) Transforming growth factorbeta1is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol 161:2179–2193
2. Almanzar M, Frazier KS, Dube PH, Piqueras AI, Jones WK, Charette MF, Paredes AL (1998) Osteogenic protein-1mRNA expression is selectively modulated after acute ischemic renal injury. J Am Soc Nephrol 9:1456–1463
3. Benigni A, Zoja C, Campana M, Corna D, Sangalli F, Rottoli D, Gagliardini E, Conti S, Ledbetter S, Remuzzi G (2006) Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started. Nephron Exp Nephrol 104:e158–e168
4. Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10:1257–1272
5. Borovecki F, Jelic M, Grgurevic L, Sampath KT, Bosukonda D, Vukicevic S (2004) Bone morphogenetic protein-7 from serum of pregnant mice is available to the fetus through placental transfer during early stages of development. Nephron Exp Nephrol 97:e26–e32